The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection
Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000000830
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)